Tumor stage and molecular phenotype are both powerful predictors of the clinical behavior and therapeutic responsiveness of breast cancer. Although the most commonly used IHC biomarkers, including ER, PR, HER2, Ki-67, and PD-L1, are actively applied in practice, the dynamics of their integration and their connection wi...
Nada Hamzah Shareef Al Shabbani, Marwa Jamal Hussain Al-Kinani, I. Fahad· Acta Medica Iranica· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.